View More View Less
  • 1 Pécsi Tudományegyetem, Általános Orvostudományi Kar, Pécs, Rákóczi u. 2., 7623
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $1,070.00

Absztrakt

Európában évente 2,5 millió ember halálát daganatos és egyéb előrehaladott stádiumú krónikus betegség okozza. Ez a szám várhatóan növekedni fog az európai népesség elöregedése miatt. A krónikus progresszív betegségben szenvedők jelentős hányadának halálát elnyújtott életvégi stádium előzi meg. Ebben a szakaszban a betegeknek súlyos tünetei, fájdalmai vannak, amelyek szükségessé teszik tüneti kezelésüket, palliatív ellátásukat. Sokszor nehézségekbe ütközik a betegek életkilátásainak megítélése, a betegség prognózisának becslése, és emiatt a fokozott palliatív ellátási igényű betegek korai meghatározása, kiválasztása. Az alábbi közlemény a „jó palliatív ellátás” alapelemeinek ismertetése során a leggyakrabban előforduló krónikusbetegség-lefolyási modelleket és azokat a faktorokat is bemutatja, amelyek használata segíti a gyakorló orvosokat abban, hogy könnyebben felismerjék a fokozott palliatív ellátási igényű betegeket és ezáltal már a betegség korábbi szakaszában is a betegek igényeinek megfelelőbb ellátást nyújthassanak. Orv. Hetil., 2015, 156(42), 1703–1709.

  • 1

    Vos, T., Flaxman, D. A., Naghavi, M., et al.: Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012, 380(9859), 2163–2196.

  • 2

    Obermeyer, Z., Makar, M., Abujaber, S., et al.: Association between the Medicare hospice benefit and health care utilization and costs for patients with poor-prognosis cancer. JAMA, 2014, 312(18), 1888–1896.

  • 3

    Zhang, B., Wright, A. A., Huskamp, H. A., et al.: Health care costs in the last week of life: associations with end of life conversations. Arch. Intern. Med., 2009, 169(5), 480–488.

  • 4

    Casarett, D., Pickard, A., Bailey, F. A., et al.: Do palliative care consultations improve patient outcomes? J. Am. Geriatr. Soc., 2008, 56(4), 593–599.

  • 5

    Morrison, R. S., Penrod, J. D., Cassel, J. B., et al.: Cost savings associated with US hospital palliative care consulation programs. Arch. Intern. Med., 2008, 168(16), 1783–1790.

  • 6

    Temel, J. S., Greer, J. A., Muzikansky, A., et al.: Early palliative care for patients with metastatic non-small-cell lung cancer. N. Engl. J. Med., 2010, 363(8), 733–742.

  • 7

    Connor, S. R., Pyenson, B., Fitch, K., et al.: Comparing hospice and nonhospice patient survival among patients who die within a three-year window. J. Pain Symptom Manage., 2007, 33(3), 238–246.

  • 8

    Greer, J. A., Jackson, V. A., Meier, D. E., et al.: Early integration of palliative care services with standard oncology care for patients with advanced cancer. CA Cancer J. Clin., 2013, 63(5), 349–363.

  • 9

    Taylor, D. H. Jr., Bull, J., Zhong, X., et al.: The effect of palliative care on patient functioning. J. Palliat. Med., 2013, 16(10), 1227–1231.

  • 10

    Gadoud, A., Jenkins, S. M., Hogg, K. J.: Palliative care for people with heart failure: Summary of current evidence and future direction. Palliat. Med., 2013, 27(9), 822–828.

  • 11

    Boland, J., Martin, J., Wells, A. U., et al.: Palliative care for people with non-malignant lung disease: Summary of current evidence and future direction. Palliat. Med., 2013, 27(9), 811–816.

  • 12

    Beernaert, K., Cohen, J., Deliens, L., et al.: Referral to palliative care in COPD and other chronic diseases: a population-based study. Respir. Med., 2013, 107(11), 1731–1739.

  • 13

    Solano, J. P., Gomes, B., Higginson, I. J.: A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J. Pain Symptom Manage., 2006, 31(1), 58–68.

  • 14

    Edmonds, P., Karlsen, S., Khan, S., et al.: A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat. Med., 2001, 15(4), 287–295.

  • 15

    McKinley, R. K., Stokes, T., Exley, C., et al.: Care of people dying with malignant and cardiorespiratory disease in general practice. Br. J. Gen. Pract., 2004, 54(509), 909–913.

  • 16

    Stage, K. B., Middelboe, T., Stage, T. B., et al.: Depression in COPD – management and quality of life considerations. Int. J. Chron. Obstruct. Pulmon. Dis., 2006, 1(3), 315–320.

  • 17

    Rutledge, T., Reis, V. A., Linke, S. E., et al.: Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J. Am. Coll. Cardiol., 2006, 48(8), 1527–1537.

  • 18

    Jiang, W., Kuchibhatla, M., Clary, G. L., et al.: Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am. Heart J., 2007, 154(1), 102–108.

  • 19

    Salerno, F. G., Carone, M.: Anxiety and depression in COPD. Multidiscip. Respir. Med., 2011, 6(4), 212–213.

  • 20

    LeGrand, S. B., Khawam, E. A., Walsh, D., et al.: Opioids, respiratory function, and dyspnea. Am. J. Hosp. Palliat. Care, 2003, 20(1), 57–61.

  • 21

    Jennings, A. L., Davies, A. N., Higgins, J. P., et al.: A systematic review of the use of opioids in the management of dyspnoea. Thorax, 2002, 57(11), 939–944.

  • 22

    Chan, J. D., Treece, P. D., Engelberg, R. A., et al.: Narcotic and benzodiazepine use after withdrawal of life support: association with time to death? Chest, 2004, 126(1), 286–293.

  • 23

    Daly, B. J., Thomas, D., Dyer, M. A.: Procedures used in withdrawal of mechanical ventilation. Am. J. Crit. Care, 1996, 5(5), 331–338.

  • 24

    Stone, P., Phillips, C., Spruyt, O., et al.: A comparison of the use of sedatives in a hospital support team and in a hospice. Palliat. Med., 1997, 11(2), 140–144.

  • 25

    Thorns, A., Sykes, N.: Opioid use in last week of life and implications for end-of-life decision-making. Lancet, 2000, 356(9227), 398–399.

  • 26

    Simon, S. T., Higginson, I. J., Booth, S., et al.: Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst. Rev., 2010, 20(1), CD007354.

  • 27

    Ekström, M. P., Bornefalk-Hermansson, A., Abernethy, A. P., et al.: Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study. Br. Med. J., 2014, 348, g445.

  • 28

    Abernethy, A. P., McDonald, C. F., Frith, P. A., et al.: Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet, 2010, 376(9743), 784–793.

  • 29

    Uronis, H. E., Abernethy, A. P.: Oxygen for relief of dyspnea: what is the evidence? Curr. Opin. Support Palliat. Care, 2008, 2(2), 89–94.

  • 30

    Emanuel, L. L., von Gunten, C. F., Ferris, F. D.: Advance care planning. Arch. Fam. Med., 2000, 9(10), 1181–1187.

  • 31

    Detering, K. M., Hancock, A. D., Reade, M. C., et al.: The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. Br. Med. J., 2010, 340, c1345.

  • 32

    Murray, S. A., Kendall, M., Boyd, K., et al.: Illness trajectories and palliative care. Br. Med. J., 2005, 330(7498), 1007–1011.

  • 33

    United Nations: World Population Prospects: The 2012 Revision. http://esa.un.org/wpp.

  • 34

    Lynn, J., Forlini, J. H.: “Serious and complex illness“ in quality improvement and policy reform for end-of-life care. J. Gen. Intern. Med., 2001, 16(5), 315–319.

  • 35

    Causes of death statistics, 2014. http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Causes_of_death_statistics

  • 36

    The GSF Prognostic Indicator Guidance, 4th edition, 2011. http://www.goldstandardsframework.org.uk

  • 37

    MCCN Guidelines for the identifications of patients in the last 12 months of life, 2012. http://www.mccn.nhs.uk/fileuploads/File/Guidelines

  • 38

    Weiss, B. D., Lee, E.: Hospice eligibility for patients with COPD. 2010. http://202.154.59.182/ejournal/files/A%20Resource%20for%20Providers.pdf

  • 39

    Thoonsen, B., Engels, Y., van Rijswijk, E..: Early identification of palliative care patients in general practice: development of RADbound indicators for Palliative Care Needs (RADPAC). Br. J. Gen. Pract., 2012, 62(602), e625–e631.

 

The author instructions are available in PDF.
Instructions for Authors in Hungarian HERE.

 

Mendeley citation style is available HERE.
  • Impact Factor (2019): 0.497
  • Scimago Journal Rank (2018): 0.176
  • SJR Hirsch-Index (2018): 20
  • SJR Quartile Score (2018): Q3 Medicine (miscellaneous)
  • Impact Factor (2018): 0.564
  • Scimago Journal Rank (2018): 0.193
  • SJR Hirsch-Index (2018): 18
  • SJR Quartile Score (2018): Q3 Medicine (miscellaneous)

Language: Hungarian

Founded in 1857
Publication: Weekly, one volume of 52 issues annually

Senior editors

Editor(s)-in-Chief: Papp Zoltán

Read the professional career of Papp Zoltán HERE.

 

Editorial Board

Click for the Editorial Board

Akadémiai Kiadó
Address: Prielle Kornélia u. 21-35. H-1117 Budapest, Hungary
Phone: (+36 1) 464 8235 ---- Fax: (+36 1) 464 8221
Email: orvosihetilap@akkrt.hu